BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petkar KC, Patil SM, Chavhan SS, Kaneko K, Sawant KK, Kunda NK, Saleem IY. An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 2021;13:455. [PMID: 33801614 DOI: 10.3390/pharmaceutics13040455] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Brito C, Lourenço C, Magalhães J, Reis S, Borges M. Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii. Vaccines 2023;11:733. [DOI: 10.3390/vaccines11040733] [Reference Citation Analysis]
2 Li S, Zhang MY, Yuan J, Zhang YX. Nano-vaccines for gene delivery against HIV-1 infection. Expert Rev Vaccines 2023. [PMID: 36945780 DOI: 10.1080/14760584.2023.2193266] [Reference Citation Analysis]
3 Yu YB, Liu Y, Li S, Yang XY, Guo Z. The pH-responsive zeolitic imidazolate framework nanoparticle as a promising immune-enhancing adjuvant for anti-caries vaccine. J Dent 2023;130:104413. [PMID: 36634754 DOI: 10.1016/j.jdent.2023.104413] [Reference Citation Analysis]
4 Zafar A, Arshad R, Ur Rehman A, Ahmed N, Akhtar H. Recent Developments in Oral Delivery of Vaccines Using Nanocarriers. Vaccines (Basel) 2023;11. [PMID: 36851367 DOI: 10.3390/vaccines11020490] [Reference Citation Analysis]
5 Yavuz E, Dursun S, Kara M, Dinc S. Role of metal nanoparticles for treatment of and prevention of viral infections. Smart Nanomaterials to Combat the Spread of Viral Infections 2023. [DOI: 10.1016/b978-0-323-99148-3.00003-0] [Reference Citation Analysis]
6 Dahiya S, Dahiya R. An Overview on Nanocarriers for Nasal Delivery. Nasal Drug Delivery 2023. [DOI: 10.1007/978-3-031-23112-4_9] [Reference Citation Analysis]
7 Huo J, Zhang A, Wang S, Cheng H, Fan D, Huang R, Wang Y, Wan B, Zhang G, He H. Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection. J Nanobiotechnology 2022;20:514. [PMID: 36463277 DOI: 10.1186/s12951-022-01730-0] [Reference Citation Analysis]
8 de Moura IA, Silva AJD, de Macêdo LS, Invenção MDCV, de Sousa MMG, de Freitas AC. Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems. Pathogens 2022;11. [PMID: 36558778 DOI: 10.3390/pathogens11121444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mamuti M, Chen W, Jiang X. Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200080] [Reference Citation Analysis]
10 Gupta M, Wahi A, Sharma P, Nagpal R, Raina N, Kaurav M, Bhattacharya J, Rodrigues Oliveira SM, Dolma KG, Paul AK, de Lourdes Pereira M, Wilairatana P, Rahmatullah M, Nissapatorn V. Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines (Basel) 2022;10. [PMID: 36560420 DOI: 10.3390/vaccines10122011] [Reference Citation Analysis]
11 Valenzuela-Fernández A, Cabrera-Rodriguez R, Ciuffreda L, Perez-Yanes S, Estevez-Herrera J, González-Montelongo R, Alcoba-Florez J, Trujillo-González R, García-Martínez de Artola D, Gil-Campesino H, Díez-Gil O, Lorenzo-Salazar JM, Flores C, Garcia-Luis J. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Front Bioeng Biotechnol 2022;10:1052436. [PMID: 36507266 DOI: 10.3389/fbioe.2022.1052436] [Reference Citation Analysis]
12 Al-Nemrawi NK, Darweesh RS, Al-Shriem LA, Al-Qawasmi FS, Emran SO, Khafajah AS, Abu-Dalo MA. Polymeric Nanoparticles for Inhaled Vaccines. Polymers (Basel) 2022;14:4450. [PMID: 36298030 DOI: 10.3390/polym14204450] [Reference Citation Analysis]
13 Lin Z, Chen Y, Wu Y, Chen M. Highly Stable Gold Nanoparticle-Antigen Conjugates with Self-Adjuvanting Property for Induction of Robust Antigen-Specific Immune Responses. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112897] [Reference Citation Analysis]
14 Nahar UJ, Toth I, Skwarczynski M. Mannose in vaccine delivery. J Control Release 2022;351:284-300. [PMID: 36150579 DOI: 10.1016/j.jconrel.2022.09.038] [Reference Citation Analysis]
15 Huang T, Peng L, Han Y, Wang D, He X, Wang J, Ou C. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects. Front Immunol 2022;13:922301. [DOI: 10.3389/fimmu.2022.922301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ko C, Zang S, Zhou Y, Zhong Z, Yang C. Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01582-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Azuar A, Madge HYR, Boer JC, Gonzalez Cruz JL, Wang J, Khalil ZG, Deceneux C, Goodchild G, Yang J, Koirala P, Hussein WM, Capon RJ, Plebanski M, Toth I, Skwarczynski M. Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus. Vaccines (Basel) 2022;10:1212. [PMID: 36016100 DOI: 10.3390/vaccines10081212] [Reference Citation Analysis]
18 Tan J, Ding B, Zheng P, Chen H, Ma P, Lin J. Hollow Aluminum Hydroxide Modified Silica Nanoadjuvants with Amplified Immunotherapy Effects through Immunogenic Cell Death Induction and Antigen Release. Small 2022;:e2202462. [PMID: 35896867 DOI: 10.1002/smll.202202462] [Reference Citation Analysis]
19 Aqib AI, Zaheer T, Usman M, Arslan M, Atta K. Commercialization of Nanovaccines: Utopia or a Reality? Nanovaccinology as Targeted Therapeutics 2022. [DOI: 10.1002/9781119858041.ch17] [Reference Citation Analysis]
20 Li M, Liang Z, Chen C, Yu G, Yao Z, Guo Y, Zhang L, Bao H, Fu D, Yang X, Wang H, Xue C, Sun B. Virus-Like Particle-Templated Silica-Adjuvanted Nanovaccines with Enhanced Humoral and Cellular Immunity. ACS Nano 2022. [PMID: 35763693 DOI: 10.1021/acsnano.2c01283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Figueiredo DB, Kaneko K, Rodrigues TDC, MacLoughlin R, Miyaji EN, Saleem I, Gonçalves VM. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs. Pharmaceutics 2022;14:1238. [PMID: 35745810 DOI: 10.3390/pharmaceutics14061238] [Reference Citation Analysis]
22 Xu Y, Huang M, Chen X, He X, Guo X, Zhou Z, Deng Y, Li S, Chen Z. Applications of nano materials in the treatment, prevention and detection of herpes virus: A review. mat express 2022;12:629-644. [DOI: 10.1166/mex.2022.2186] [Reference Citation Analysis]
23 Dykman LA, Staroverov SA, Fomin AS, Gabalov KP. Obtaining antibodies to silymarin using the adjuvant properties of gold nanoparticles and their application to study the uptake of silymarin into cells. Computational Biophysics and Nanobiophotonics 2022. [DOI: 10.1117/12.2625711] [Reference Citation Analysis]
24 Liu S, Kang M, Zhao N, Zhuang Y, Li S, Song T. Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities. Medical Review 2022;2:169-196. [DOI: 10.1515/mr-2021-0021] [Reference Citation Analysis]
25 Masuda A, Lee JM, Miyata T, Mon H, Sato K, Oyama K, Sakurai Y, Yasuda J, Takahashi D, Ueda T, Kato Y, Nishida M, Karasaki N, Kakino K, Ebihara T, Nagasato T, Hino M, Nakashima A, Suzuki K, Tonooka Y, Tanaka M, Moriyama T, Nakatake H, Fujita R, Kusakabe T. Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants. Front Immunol 2021;12:803647. [PMID: 35095889 DOI: 10.3389/fimmu.2021.803647] [Reference Citation Analysis]
26 Tan J, Ding B, Teng B, Ma P, Lin J. Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy. Adv Funct Materials 2022;32:2111670. [DOI: 10.1002/adfm.202111670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Nwagwu CS, Ugwu CN, Ogbonna JDN, Onugwu AL, Agbo CP, Echezona AC, Ezeibe EN, Uzondu S, Kenechukwu FC, Akpa PA, Momoh MA, Nnamani PO, Tarirai C, Ofokansi KC, Attama AA. Recent and advanced nano-technological strategies for COVID-19 vaccine development. Covid-19: Biomedical Perspectives 2022. [DOI: 10.1016/bs.mim.2022.03.001] [Reference Citation Analysis]
28 Tabarzad M, Mohit E, Ghorbani-bidkorbeh F. Nanovaccines delivery approaches against infectious diseases. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00002-6] [Reference Citation Analysis]
29 Sun Z, Li W, Lenzo JC, Holden JA, Mccullough MJ, O’connor AJ, O’brien-simpson NM. The Potential of Calcium Phosphate Nanoparticles as Adjuvants and Vaccine Delivery Vehicles. Front Mater 2021;8:788373. [DOI: 10.3389/fmats.2021.788373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Popa A, Springer S. Tailored Nanoparticles as Vaccine Components. Applied Sciences 2021;11:11898. [DOI: 10.3390/app112411898] [Reference Citation Analysis]
31 Cordeiro AS, Patil-Sen Y, Shivkumar M, Patel R, Khedr A, Elsawy MA. Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 2021;13:2091. [PMID: 34959372 DOI: 10.3390/pharmaceutics13122091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Pogostin BH, McHugh KJ. Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness. Bioengineering (Basel) 2021;8:155. [PMID: 34821721 DOI: 10.3390/bioengineering8110155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Das A, Ali N. Nanovaccine: an emerging strategy. Expert Rev Vaccines 2021;20:1273-90. [PMID: 34550859 DOI: 10.1080/14760584.2021.1984890] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
34 Celis-Giraldo CT, López-Abán J, Muro A, Patarroyo MA, Manzano-Román R. Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines (Basel) 2021;9:988. [PMID: 34579225 DOI: 10.3390/vaccines9090988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Serra AS, Eusébio D, Neves AR, Albuquerque T, Bhatt H, Biswas S, Costa D, Sousa Â. Synthesis and Characterization of Mannosylated Formulations to Deliver a Minicircle DNA Vaccine. Pharmaceutics 2021;13:673. [PMID: 34067176 DOI: 10.3390/pharmaceutics13050673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]